Diabetes, Vol 48, Issue 10 2015-2021, Copyright © 1999 by American Diabetes Association

ARTICLES

Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas

C Saillan-Barreau, M Dufresne, P Clerc, D Sanchez, H Corominola, C Moriscot, O Guy-Crotte, C Escrieut, N Vaysse, R Gomis, N Tarasova and D Fourmy
INSERM U151, Institut Louis Bugnard, CHU Rangueil, Toulouse, France.

Gastrin (G) and cholecystokinin (CCK) are gastrointestinal neuropeptides that are released into circulation during a meal. G is also transiently expressed during embryogenic and early ontogenic development of the pancreas and is believed to act on islet-cell development. Both peptides act on pancreatic endocrine function; however, the effects are dependent on the species and on cellular and molecular underlying mechanisms that remain poorly characterized. Since CCK-B/G subtype receptor is predominant over the CCK-A subtype in the human pancreas, we hypothesized that it could be expressed by islet cells. Here we present reverse transcription-polymerase chain reaction and immunohistochemistry data demonstrating that the CCK-B/G receptor is expressed in islet cells and that islet glucagon-producing cells are the major site of CCK-B/G receptor expression in adult and fetal pancreas. Moreover, G immunoreactivity was detected in the fetal human pancreas at embryogenic week 22. G- and CCK-stimulated glucagon are released from purified human islets. Concentration of CCK and G eliciting a half-maximal level of glucagon secretion were 13 +/- 6 and 8 +/- 5 pmol/l, respectively. Maximal glucagon secretion was achieved in the presence of 30 pmol/l peptides and was similar to that obtained in the presence of 10 mmol/l L-arginine (1.6 pmol x ml(-1) x 90 min(-1)). The nonpeptide antagonist of the CCK-B/G receptor, RPR-101048, fully inhibited CCK- and G-stimulated glucagon secretion at 100 nmol/l concentration. These data are consistent with the view that the CCK-B/G receptor is involved in glucose homeostasis in adult humans and mediates the autocrine effects of G on islet differentiation and growth in the fetal pancreas.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Clerc, M. G. Coll Constans, H. Lulka, S. Broussaud, C. Guigne, S. Leung-Theung-Long, C. Perrin, C. Knauf, C. Carpene, L. Penicaud, et al. Involvement of Cholecystokinin 2 Receptor in Food Intake Regulation: Hyperphagia and Increased Fat Deposition in Cholecystokinin 2 Receptor-Deficient Mice Endocrinology, March 1, 2007; 148(3): 1039 - 1049. [Abstract] [Full Text] [PDF]

				M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]

				S. Schulz, C. Rocken, C. Mawrin, and S. Schulz Immunohistochemical Localization of CCK1 Cholecystokinin Receptors in Normal and Neoplastic Human Tissues J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6149 - 6155. [Abstract] [Full Text] [PDF]

				E. Bertelli and M. Bendayan Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development? J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086. [Abstract] [Full Text] [PDF]

				S. Leung-Theung-Long, E. Roulet, P. Clerc, C. Escrieut, S. Marchal-Victorion, B. Ritz-Laser, J. Philippe, L. Pradayrol, C. Seva, D. Fourmy, et al. Essential Interaction of Egr-1 at an Islet-specific Response Element for Basal and Gastrin-dependent Glucagon Gene Transactivation in Pancreatic {alpha}-Cells J. Biol. Chem., March 4, 2005; 280(9): 7976 - 7984. [Abstract] [Full Text] [PDF]

				J. Morisset, S. Julien, and J. Laine Localization of Cholecystokinin Receptor Subtypes in the Endocine Pancreas J. Histochem. Cytochem., November 1, 2003; 51(11): 1501 - 1513. [Abstract] [Full Text] [PDF]

				J. C. Reubi Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev., August 1, 2003; 24(4): 389 - 427. [Abstract] [Full Text] [PDF]

				E. L. Holicky, E. M. Hadac, X.-Q. Ding, and L. J. Miller Molecular characterization and organ distribution of type A and B cholecystokinin receptors in cynomolgus monkey Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G507 - G514. [Abstract] [Full Text] [PDF]

				B. Ahrén, J. J. Holst, and S. Efendic Antidiabetogenic Action of Cholecystokinin-8 in Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1043 - 1048. [Abstract] [Full Text]